Skip to main content
. 2023 Dec 4;76(6):e20220677. doi: 10.1590/0034-7167-2022-0677

Table 3. Distribution of individuals according to sarcopenia classification and association with sociodemographic, clinical, anthropometric characteristics, sarcopenia components, and quality of life.

Sarcopenia by CC Sarcopenia by ASMI
Variables Non-sarcopenia Probable sarcopenia Sarcopenia p value * Non-sarcopenia Probable sarcopenia Sarcopenia p value *
n(%) n(%) n(%) n(%) n(%) n(%)
Sociodemographic
Age (years) 59.4±7.9 (56.7-62.2) 62.6±6.9 (60.1-65.6) 63.4±9.4 (59.8-66.9) 0.172 59.4±7.9 (56.2-62.8) 61.4±6.5 (59.4-63.4) 67.4±10.5 (61.0-73.9) 0.060
Age group 0.122 0.111
Adult 17(43.6) 12(30.8) 10(25.6) 17(43.6) 17(43.6) 5(12.8)
Elder 10(22.7) 17(38.6) 17(38.6) 10(22.7) 24(54.5) 10(22.7)
Sex 0.059 0.062
Male 24(40.0) 18(30.0) 18(30.0) 24(40.0) 26(43.3) 10(16.7)
Female 3(13.0) 11(47.8) 9(39.1) 3(13.0) 15(65.2) 5(21.7)
Race 0.660 0.401
White/Hispanic 14(31.8) 14(31.8) 16(36.4) 14(31.8) 19(43.2) 11(25.0)
Black/African-American 13(34.2) 14(36.8) 11(28.9) 13(34.2) 21(55.3) 4(10.5)
Asian - 1(100.0) - - 1(100.0) -
Marital status 0.548 0.575
Married 15(30.6) 19(38.8) 15(30.6) 15(30.6) 26(53.1) 8(16.3)
Single 4(50.0) 2(25.0) 2(25.0) 4(50.0) 4(50.0) -
Widowed 4(25.0) 7(43.8) 5(31.3) 4(25.0) 7(43.8) 5(31.3)
Divorced 4(40.0) 1(10.0) 5(50.0) 4(40.0) 4(40.0) 2(20.0)
Work activity 0.678 0.546
No 25(33.8) 26(35.1) 23(31.1) 25(33.8) 35(47.3) 14(18.9)
Yes 2(22.2) 3(33.3) 4(44.4) 2(22.2) 6(66.7) 1(11.1)
Economic level 0.907 0.375
A - - - - - -
B 7(35.0) 7(35.0) 6(30.0) 7(35.0) 7(35.0) 6(30.0)
C 12(27.9) 16(37.2) 15(349) 12(27.9) 24(55.8) 7(16.3)
D and E 8(40.0) 6(30.0) 6(30.0) 8(40.0) 10(50.0) 2(10.0)
Clinical
Comorbidities 0.238 0.390
None 3(50.0) 3(50.0) - 3(50.0) 2(33.3) 1(16.7)
1 to 2 20(32.8) 18(29.5) 23(37.7) 20(32.8) 28(45.9) 13(21.3)
3 or more 4(25.0) 8(50.0) 4(25.0) 4(25.0) 11(68.8) 1(6.3)
Metabolic stress 0.291 0.693
None 22(32.8) 26(38.8) 19(28.4) 22(32.8) 33(49.3) 12(17.9)
Low 3(42.9) 2(28.6) 2(28.6) 3(42.9) 4(57.1) -
Moderate 2(28.6) 1(14.3) 4(57.1) 2(28.6) 3(42.9) 2(28.6)
Elevated - - 2(100.0) - 1(50.0) 1(50.0)
Disease information
Treatment time (months) 33.5±27.8 (23.9-44.5) 35.6±35.3 (24.5-47.6) 36.9±37.6 (22.1-53.6) 0.930 33.5±27.8 (23.7-44.7) 38.0±37.7 (27.2-50.5) 31.4±32.8 (16.4-49.2) 0.789
Time of kidney disease (months) 34.5±27.2 (11.0-53.0) 38.4±34.8 (13.0-50.5) 33.3±33.0 (8.0-43.0) 0.667 34.5±7.5 (11.0-53.0) 37.6±33.7 (15.5-44.0) 31.4±34.4 (6.0-58.0) 0.641
TFGe (ml/min) 7.5±3.3 (4.9-6.9) 7.4±2.7 (5.2-9.5) 8.8±5.2 (5.8-9.3) 0.486 7.5±3.3 (4.9-9.4) 7.9±4.3 (5.3-9.5) 8.3±3.7 (6.2-9.3) 0.611
Anthropometry
Weight (kg) 75.4±15.8 (70.0-81.2)a 74.1±8.9 (70.5-77.7)a 58.9±7.8 (55.9-61.9)b <0.001 75.4±15.8 (69.8-81.6)a 70.3±10.2 (66.8-73.5)a 57.1±8.1 (53.1-61.7)b <0.001
Height (m) 1.70±0.08 (1.67-1.73)a 1.65±0.08 (1.62-1.68)a.b 1.62±0.08 (1.59-1.65)b 0.004 1.70±0.08 (1.66-1.73)a 1.63±0.08(1.60-1.66)b 1.65±0.07(1.61-1.69)a.b 0.006
BMI (kg/m2) 26.2±5.4 (24.3-28.4)a 27.4±3.1 9 (26.1-28.7)a 22.3±2.3 (21.5-23.2)b <0.001 26.2±5.4 (24.5-28.2)a 26.4±3.1 (25.3-27.5)a 20.9±2.0 (19.8-22.1)b <0.001
APMT R (mm) 9.8±3.3 (8.6-11.2) 9.7±3.8 (8.4-11.2) 9.4±4.2 (7.7-11.0) 0.910 9.8±3.3 (8.7-11.0) 9.3±3.7 (8.2-10.5) 10.3±4.7 (7.8-13.0) 0.699
APMT L (mm) 10.3±5.9 (8.7-12.5) 9.4±2.7 (8.4-10.5) 8.5±3.1 (7.2-9.6) 0.290 10.3±5.9 (8.5-12.4) 9.1±2.7 (8.3-10.0) 8.6±3.3 96.9-10.3) 0.483
Sarcopenia components
Calf circumference <0.001 0.010
Adequate 17 (37.0) 29 (63.0) - 17(37.0) 26(56.5) 3(6.5)
Low muscle mass 10 (27.0) - 27 (73.0) 10(27.0) 15(40.5) 12(32.4)
CC (cm) 36.0±3.8 (34.5-37.5)a 37.0±2.0 (36.1-37.7)a 31.0±2.1 (30.2-31.8)b <0.001 36.0±3.8 (34.5-37.5)a 35.1±3.0 (34.2-36.1)a 31.0±3.5 (29.1-33.0)b <0.001
ASMI 0.001 <0.001
Adequate 25(37.9) 26(39.4) 15(22.7) 25(37.9) 41(62.1) -
Low muscle mass 2(11.8) 3(17.6) 12(70.6) 2(11.8) - 15(88.2)
ASMI (kg/m2) 10.1±1.8 (9.4-10.8) a 9.8±1.4 (9.2-10.3) a 8.4±1.4 (7.9-9.0) b <0.001 10.1±1.8 (9.4-10.8)a 9.6±1.4 (9.1-10.0)a 7.9±1.1 (7.2-8.5)b <0.001
Handgrip strength <0.001 <0.001
Adequate 27(100.0) - - 27(100.0) - -
Low muscle strength - 29(51.8) 27(48.2) - 41(73.2) 15(26.8)
HGS (kgf) 38.5±7.0 (35.7-41.2)a 20.8±5.7 (18.6-22.9)b 21.1±6.2 (18.7-23.5)b <0.001 38.5±7.0 (35.7-41.2)a 21.6±5.7 (19.8-23.4)b 19.3±6.2 (15.8-22.7)b <0.001
Gait speed 0.141 0.132
Adequate 23(39.0) 19(32.2) 17(28.8) 23(39.0) 27(45.8) 9(15.3)
Low gait speed 4(16.7) 10(41.7) 10(41.7) 4(16.7) 14(58.3) 6(25.0)
GS (m/s) 1.05±0.23 (0.95-1.14)a 0.86±0.25 (0.77-0.96)b 0.81±0.24 (0.72-0.91)b 0.002 1.05±0.24 (0.95-1.14)a 0.85±0.23 (0.78-0.92)b 0.81±0.30 (0.64-0.97)b 0.002
Quality of life (QoL)
Physical Health (PH) 65.7±14.0 (60.2-71.3) 60.5±17.5 (53.8-67.1) 57.3±17.2 (50.4-64.1) 0.165 65.7±14.0 (60.2-71.3) 60.0±16.6 (54.7-65.3) 55.9±19.3 (45.3-66.6) 0.153
Psychological Health (PSH) 83.3±16.4 (76.3-89.7) 77.1±19.3 (68.7-84.8) 80.7±15.3 (73.8-87.0) 0.458 83.3±16.4 (77.2-89.9) 79.7±18.5 (73.4-85.8) 76.5±14.6 (69.1-84.0) 0.399
Social Relationships (SR) 78.1±24.5 (68.1-87.5) 73.7±26.6 (62.9-83.4) 76.0±23.1 (66.2-85.0) 0.827 78.1±24.5 (69.2-85.9) 77.5±24.6 (67.9-85.9) 67.8±24.6 (54.2-81.3) 0.411
Environment quality of life (EQL) 84.7±13.1 (78.9-90.1) 77.5±15.7 (71.4-83.3) 76.5±16.3 (70.1-82.8) 0.086 84.7±13.1 (79.3-89.7) 77.5±15.4 (72.5-82.9) 75.7±17.2 (66.2-85.60 0.092
Global QoV 65.7±21.0 (57.8-73.8) 71.1±22.0 (62.4-80.0) 66.0±20.0 (57.5-74.8) 0.600 65.7±21.0 (58.4-72.9) 70.6±22.1 (63.6-77.8) 63.4±17.3 (54.5-72.0) 0.444

CC: calf circumference; ASMI: appendicular skeletal muscle index; BMI: Body mass index; APMT: adductor pollicis muscle thickness. EGFR: estimated glomerular filtration rate.

*

Pearson's chi-square (categorical) or ANOVA (means; continuous). Matching letters: statistical similarity.